The 20 Best Ovarian Carcinosarcoma Doctors Near Me in San Francisco, CA

John Chan is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Chan is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Chan is currently accepting new patients.

Lejla Delic is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Delic is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Endometrial Cancer, Bladder Reconstruction, and Hysterectomy. Dr. Delic is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology.

Dr. Edwin Alexander Alvarez is a gynecologic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. He focuses on the surgical and medical treatment of ovarian cancer, cervical cancer, endometrial cancer and other cancers of the female reproductive system. He performs traditional, complicated and minimally invasive gynecologic surgeries. UCSF recruited Alvarez to serve as director of clinical trials for the Division of Gynecologic Oncology. He is involved with NRG Oncology, a cooperative research group for cancer clinical trials sponsored by the National Cancer Institute. Before coming to UCSF, he directed chemotherapy services for gynecologic cancers at the University of California, Davis. In addition to caring for patients, Alvarez has a strong commitment to teaching medical students, residents and fellows. Dr. Alvarez is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Hernia Surgery. Dr. Alvarez is board certified in American Board Of Obstetrics And Gynecology, Gynecologic Oncology and American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology. Dr. Alvarez is currently accepting new patients.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Shen is rated as an Advanced provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Vulvar Cancer, Endometrial Stromal Sarcoma, Oophorectomy, and Salpingo-Oophorectomy. Dr. Shen is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Shen is currently accepting new patients.

Stephanie Jeske is an Oncologist practicing medicine in San Francisco, California. Dr. Jeske is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Jeske is currently accepting new patients.

Caroline Behler is a Hematologist practicing medicine in San Francisco, California. Dr. Behler is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 72 other conditions, according to our data. Her clinical expertise encompasses Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Bone Marrow Aspiration, and Gamma Knife Radiosurgery.

Caring, compassionate, and patient centric care. Dr. Quock is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Quock is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Quock is currently accepting new patients.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Heart Tumor, Colorectal Cancer, Familial Colorectal Cancer, Endoscopy, and Bone Marrow Aspiration. Dr. Chan is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Chan is currently accepting new patients.

Lee-may Chen is an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Desmoplastic Small Round Cell Tumor, Salpingo-Oophorectomy, and Oophorectomy.

Stefanie Ueda is an Oncologist practicing medicine in San Francisco, California. Dr. Ueda is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Bladder Reconstruction, and Hysterectomy.

Donald Abrams is an Oncologist practicing medicine in San Francisco, California. Dr. Abrams is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Familial Prostate Cancer.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is rated as an Advanced provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

Hope Rugo is an Oncologist practicing medicine in San Francisco, California. Dr. Rugo is rated as an Advanced provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Bone Marrow Aspiration, and Hormone Replacement Therapy (HRT).

Ari Baron is an Oncologist practicing medicine in San Francisco, California. Dr. Baron is rated as an Advanced provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 63 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Liver Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration.

Dr. Chia-Ching Wang, who goes by Jackie, is an oncologist who treats anal cancer. She also provides cancer screenings with high-resolution anoscopy (an examination using an instrument that can be inserted into the anal canal). Wang's work in research focuses on HIV oncology, particularly HPV-related cancers. (HIV-infected individuals may be at higher risk for developing HPV-related cancers due to their immunosuppression. She hopes to develop and implement prevention strategies, as well as test novel therapies that may improve outcomes for patients with these cancers.) She has also completed studies on lymphoma and Kaposi's sarcoma. She has special interests in superficially invasive squamous cell carcinoma of the anus and in post-treatment surveillance. Wang received her medical degree from the State University of New York at Stony Brook. She began a residency in obstetrics and gynecology at Women & Infants Hospital of Rhode Island, but after the first year, she decided to change her focus to HIV-related work. She subsequently completed a research fellowship at the Miriam Hospital, a teaching affiliate of the Warren Alpert Medical School of Brown University. She then completed a residency in internal medicine at Brown University. After working for a year as a hospitalist (a physician dedicated to patient care in the hospital setting), she came to UCSF for a fellowship in hematology and oncology. Wang is a member of the American Society of Hematology, American Society of Clinical Oncology and American Medical Association. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Lung Cancer. Dr. Wang is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine/Hematology, Hematology. Dr. Wang is currently accepting new patients.

Dr. Katherine Fuh is a gynecologic oncologist who specializes in diagnosing and managing cancers of the female reproductive system, including advanced ovarian and uterine cancers. Her expertise includes chemotherapy, targeted therapy and immunotherapy. Fuh earned her medical degree at Georgetown University School of Medicine. She completed a residency in obstetrics and gynecology at Stanford University, where she also earned a doctorate in cancer biology. She completed a fellowship in gynecologic oncology through a joint program of UCSF and Stanford Medicine. As a physician-scientist, Fuh studies how to improve outcomes for patients with ovarian or uterine cancer. She is nationally known for her use of molecular biomarkers (measurable biological indicators of disease) to guide and personalize therapy. Her laboratory focuses on identifying biomarkers associated with treatment resistance in patients with ovarian cancer and developing targeted therapies to overcome the resistance. She has been involved in numerous clinical trials (studies that use human volunteers to evaluate promising treatments) and is the principal investigator for one of the first clinical trials of a new drug for patients with treatment-resistant metastatic ovarian cancer. She is also the principal investigator on multiple research projects that received grants from various federal funders and foundations. She has published many scientific papers on gynecologic cancers, and her research has advanced how doctors approach treating these diseases. Prior to joining UCSF, Fuh was a faculty member at Washington University School of Medicine in St. Louis. In addition to directing translational and basic research there, she was an integral member of the division of gynecologic cancer and the cancer center. Dr. Fuh is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Oophorectomy, and Hysterectomy. Dr. Fuh is board certified in American Board Of OB/Gynecologic Oncology, Gynecologic Oncology and American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology. Dr. Fuh is currently accepting new patients.

Dr. Stephanie Cham is a gynecologic oncologist, a specialist in treating cancers of the female reproductive organs. She is passionate about providing patients with high-quality surgical care and about teaching medical students how to deliver this care. Cham joined UCSF as a National Institutes of Health scholar focused on women's reproductive health and how to best provide cancer care, particularly for frail and elderly patients. Her research often focuses on improving care around the time of surgery for patients with gynecologic cancers, particularly in vulnerable populations. She specifically looks at how new technologies and other health care services influence patient outcomes. Her research has been presented at national conferences and published in major medical journals. Cham earned her medical degree at the David Geffen School of Medicine at UCLA. She completed a residency in obstetrics and gynecology at New York – Presbyterian/Columbia University Irving Medical Center, followed by a fellowship in gynecologic oncology at Dana-Farber Brigham Cancer Center. Dr. Cham is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Ovarian Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Vulvectomy. Dr. Cham is board certified in American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology. Dr. Cham is currently accepting new patients.

Dr. Rahul Aggarwal is a specialist in cancers of the genital and urinary organs. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men who are receiving androgen deprivation therapy, hormone therapy for prostate cancer. As a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early-phase clinical trials of novel targeted treatments. His research focuses on developing hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. He is also interested in developing new molecular imaging techniques that will help predict how advanced solid tumors will respond to treatment. Aggarwal earned his medical degree from the Northwestern University Feinberg School of Medicine. At UCSF, he completed an internship and residency in internal medicine, followed by a clinical fellowship in hematology and oncology. Aggarwal has also been a research fellow in developmental therapeutics at Genentech. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award. Dr. Aggarwal is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Melanoma of the Eye, and Muscle Invasive Bladder Cancer. Dr. Aggarwal is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Aggarwal is currently accepting new patients.

Dr. Jo Chien specializes in caring for patients with breast cancer. She serves as medical director of breast medical oncology at UCSF. In research, Chien develops new treatments for early and metastatic breast cancer. She serves as principal investigator on numerous trials focused on all breast cancer subtypes, with the goal of tailoring treatment to tumor biology and identifying which patients need more aggressive treatment (and providing targeted treatment options for these patients) and which patients can do well with less intervention. Chien is also interested in the impact of breast cancer diagnosis and treatment on young women. She started a large registry of young women with breast cancer that serves as a resource for research and support. Chien earned her undergraduate degree from Stanford University and her medical degree from Harvard Medical School. She completed a residency in internal medicine at Massachusetts General Hospital. At UCSF, she completed a fellowship in hematology and oncology and served as chief fellow before joining the faculty. Chien has received research funding from the National Institutes of Health, National Cancer Institute, U.S. Department of Defense, American Society of Clinical Oncology, American Cancer Society and California Breast Cancer Research Program, as well as philanthropic support. She has published numerous research articles in medical journals. Dr. Chien is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Chien is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Chien is currently accepting new patients.

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is rated as an Experienced provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, and Pancreatic Cancer. Dr. Ko is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ko is currently accepting new patients.